Marketing authorisation holders for all authorised medicines in the EU are required to appoint a so-called industry single point of contact (i-SPOC) who can provide information directly to EMA about the supply and availability of critical medicines identified in the context of a major event or a public health emergency. This applies to products authorised via any procedure, whether centrally via EMA, or using national, mutual recognition or decetralised procedures.
They need to register an i-SPOC by 2 September 2022.
For more information, please read the announcement on the EMA Corporate website.
Registering an i-SPOC
Marketing authorisation holders need to identify their i-SPOC via EMA's IRIS platform.
They can log in to IRIS using their EMA account credentials.
Guidance on how to register an i-SPOC is available in the demo video on the EMA Corporate website, and in the user guide on the IRIS platform. Marketing authorisation holders who do not have an EMA account need to create one first via EMA's Account Management portal. This could take 5-10 working days. For technical support, they should contact the EMA Service Desk.